BioCentury
ARTICLE | Clinical News

Zonagen Vasomax and Vasofem update

September 8, 2000 7:00 AM UTC

ZONA said it was notified by the FDA that a partial clinical hold in effect for the company's Vasomax and Vasofem compounds may be lifted through the successful completion of a mechanistic study of br...